Filings

2 documents · 12 matches

1. ADAPY Adaptimmune Therapeutics PLC 10-Q 2025-05-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability
   10 matches in this document Show context Copy citation

2. ADAPY Adaptimmune Therapeutics PLC 10-Q 2025-08-13

   Item 1 · Note 2. Summary of Significant Accounting Policies

   Going Concern, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt
   2 matches in this document Show context Copy citation